Researchers develop synthetic antibody that, when combined with common lung cancer drug, prevents relapse of adenocarcinoma ...

The uncontrolled activity of some immune cells in the lungs impeded structural cells from repairing themselves.

THE LONG-TERM EFFECTS of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates ...

This live biotherapeutic product, tested in mouse models, shows promise in addressing common pathways of lung disease progression. This study, published in the journal Nature Communications, ...

This was demonstrated in BPD mouse models, and gain- or loss-of-function studies showed the impact of Ac-PGP. Intranasal instillation of Ac-PGP increased neutrophilic inflammation and lung ...

Surprisingly, we found that mice infected with influenza virus, rather than the COVID-19 mouse models scientists currently use, best replicated the physical features of severe chronic lung disease.

The inhibition of ERK5 is a potential complementary strategy for countering FAK inhibitor resistance in patients with lung ...

This was demonstrated in BPD mouse models, and gain- or loss-of-function studies showed the impact of Ac-PGP. Intranasal instillation of Ac-PGP increased neutrophilic inflammation and lung ...

First, we examined lung samples from patients with long COVID-19. Although these patients were infected several months to years before the samples were taken, we found evidence of an overactive immune ...

ME-01473 inhibited tumor growth in a patient-derived xenograft mouse model of non-small cell lung cancerElevated levels of soluble and ...